AngioDynamics (ANGO) 8-K Changes in Registrant's Certifying Accountant

Exhibit 16.1

October 6, 2016

Securities and Exchange Commission100 F Street, N.E.Washington, DC 20549

Commissioners:

We have read the statements made by AngioDynamics, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of AngioDynamics, Inc. dated October 4, 2016. We agree with the statements concerning our Firm in such Form 8- K.

Very truly yours,

PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP, 101 Seaport Boulevard, Suite 500, Boston, MA 02210

T: (617) 530 5000, F: (617) 530 5001, www.pwc.com/us